Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
milvia.casato@uniroma1.it
Milvia Casato
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
E-mail:
milvia.casato@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Surface antigen serocleared hepatitis B virus infection increases the risk of mixed cryoglobulinemia vasculitis in male patients with chronic hepatitis C
FRONTIERS IN IMMUNOLOGY
2024
Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients
IMMUNOLOGY LETTERS
2024
Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study
BIOMEDICINES
2023
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity
JOURNAL OF CLINICAL IMMUNOLOGY
2023
Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia
FRONTIERS IN IMMUNOLOGY
2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy
ANNALS OF HEMATOLOGY
2023
Persistence of monoclonal B-cell expansion and intraclonal diversification despite virus eradication in patients affected by hepatitis C virus-associated lymphoproliferative disorders
BRITISH JOURNAL OF HAEMATOLOGY
2023
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2023
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
CLINICAL RHEUMATOLOGY
2023
Correction to: management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
CLINICAL RHEUMATOLOGY
2023
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2
EARD
2022
Relapse of HCV-Cryoglobulinemic Vasculitis Following Sustained Viral Response after Interferon-free Direct-Acting Antivirals
THE AMERICAN JOURNAL OF GASTROENTEROLOGY
2022
Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature
AUTOIMMUNITY REVIEWS
2022
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups
JOURNAL OF AUTOIMMUNITY
2022
COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies
JOURNAL OF TRANSLATIONAL AUTOIMMUNITY
2022
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases
JOURNAL OF AUTOIMMUNITY
2022
CD21 low B cells are predictive markers of new digital ulcers in systemic sclerosis
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
2021
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders
AMERICAN JOURNAL OF HEMATOLOGY
2021
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression
RHEUMATOLOGY
2021
Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2021
1
2
3
seguente ›
ultima »
Progetti di Ricerca
The unusual CD21low B cells associated with different human disorders may be generated through Toll-like receptor tolerance
Biomarkers of endothelial and coagulation system dysfunction as predictors of active vasculitis in patients with HCV-associated and essential mixed cryoglobulinemia
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma